Clinical trials in chronic limb-threatening ischaemia.
作者信息
Farber Alik, Rosenfield Kenneth, Menard Matthew T
机构信息
Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts, USA.
Section of Vascular Medicine and Intervention Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
出版信息
Br J Surg. 2023 Mar 30;110(4):397-398. doi: 10.1093/bjs/znac465.
Abstract
摘要
相似文献
1
Clinical trials in chronic limb-threatening ischaemia.慢性肢体威胁性缺血的临床试验。
Br J Surg. 2023 Mar 30;110(4):397-398. doi: 10.1093/bjs/znac465.
2
Treatment options for patients with chronic limb-threatening ischaemia who are not candidates for revascularization.对于不适合进行血管重建的慢性肢体威胁性缺血患者的治疗选择。
Br J Surg. 2024 Jan 31;111(2). doi: 10.1093/bjs/znad416.
3
Managing Chronic Limb-Threatening Ischaemia in Patients at the Extremes of Older Age Requires a Patient-Focused Approach.管理高龄患者的慢性肢体威胁性缺血需要以患者为中心的方法。
World J Surg. 2022 Nov;46(11):2832-2833. doi: 10.1007/s00268-022-06701-y. Epub 2022 Aug 18.
4
Revascularisation for Chronic Limb Threatening Ischaemia - The Need for Speed.慢性肢体威胁性缺血的血运重建——速度的必要性。
Eur J Vasc Endovasc Surg. 2023 Aug;66(2):158-159. doi: 10.1016/j.ejvs.2023.05.010. Epub 2023 May 13.
5
Measuring What Really Matters: Disease Specific Health Related Quality of Life in Patients with Chronic Limb Threatening Ischaemia.
Eur J Vasc Endovasc Surg. 2023 Aug;66(2):252. doi: 10.1016/j.ejvs.2023.05.040. Epub 2023 May 27.
6
Endovascular reperfusion strategy for infra-popliteal chronic limb threatening ischaemia.
Lancet. 2023 May 27;401(10390):1749-1750. doi: 10.1016/S0140-6736(23)00632-3. Epub 2023 Apr 25.
7
What have we learned from two trials comparing open surgery and endovascular revascularization in patients with chronic limb threatening ischemia?
J Vasc Nurs. 2023 Dec;41(4):248-249. doi: 10.1016/j.jvn.2023.11.002.
8
Endovascular therapy or surgery for chronic limb threatening ischemia?对于慢性肢体威胁性缺血，是选择血管内治疗还是手术治疗？
Vasa. 2023 Jul;52(4):214-217. doi: 10.1024/0301-1526/a001078.
9
Trust and Time Matter When Treating Chronic Limb-Threatening Ischemia.
JAMA Surg. 2023 Jun 1;158(6):e230487. doi: 10.1001/jamasurg.2023.0487. Epub 2023 Jun 14.
10
Letter to Editor: R.E "Scoring Model to Predict Major Amputation in Patients With Chronic Limb-Threatening Ischaemia at Wound, Ischaemia, and Foot Infection Clinical Stage 4 After Endovascular Therapy" by Kobayashi et al.致编辑的信：小林等人所著的《血管内治疗后处于伤口、缺血和足部感染临床4期的慢性肢体威胁性缺血患者大截肢预测评分模型》
J Endovasc Ther. 2023 Jun;30(3):477-478. doi: 10.1177/15266028221083459. Epub 2022 Mar 14.
本文引用的文献
1
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血的手术或血管内治疗。
N Engl J Med. 2022 Dec 22;387(25):2305-2316. doi: 10.1056/NEJMoa2207899. Epub 2022 Nov 7.
2
Delays to revascularization for patients with chronic limb-threatening ischaemia.慢性肢体严重缺血患者的血运重建延迟。
Br J Surg. 2022 Jul 15;109(8):717-726. doi: 10.1093/bjs/znac109.
3
Reducing Nontraumatic Lower-Extremity Amputations by 20% by 2030: Time to Get to Our Feet: A Policy Statement From the American Heart Association.到2030年将非创伤性下肢截肢率降低20%：是时候行动起来了：美国心脏协会的政策声明
Circulation. 2021 Apr 27;143(17):e875-e891. doi: 10.1161/CIR.0000000000000967. Epub 2021 Mar 25.
4
Global vascular guidelines on the management of chronic limb-threatening ischemia.全球血管指南：慢性肢体威胁性缺血的管理。
J Vasc Surg. 2019 Jun;69(6S):3S-125S.e40. doi: 10.1016/j.jvs.2019.02.016. Epub 2019 May 28.
5
Chronic Limb-Threatening Ischemia.慢性肢体威胁性缺血
N Engl J Med. 2018 Jul 12;379(2):171-180. doi: 10.1056/NEJMcp1709326.
6
Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial.严重肢体缺血患者最佳血管内治疗与最佳手术治疗对比试验（BEST-CLI）的设计与原理
J Am Heart Assoc. 2016 Jul 8;5(7):e003219. doi: 10.1161/JAHA.116.003219.
7
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis.2000 年和 2010 年全球外周动脉疾病患病率和危险因素的估计值比较：系统评价和分析。
Lancet. 2013 Oct 19;382(9901):1329-40. doi: 10.1016/S0140-6736(13)61249-0. Epub 2013 Aug 1.
8
Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.用于评估基于导管的严重肢体缺血治疗的建议客观性能目标和临床试验设计。
J Vasc Surg. 2009 Dec;50(6):1462-73.e1-3. doi: 10.1016/j.jvs.2009.09.044. Epub 2009 Nov 7.
9
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.严重下肢缺血的搭桥术与血管成形术对比研究（BASIL）：多中心随机对照试验
Lancet. 2005 Dec 3;366(9501):1925-34. doi: 10.1016/S0140-6736(05)67704-5.
10
Bypass versus angioplasty to treat severe limb ischemia: factors that affect treatment preferences of UK surgeons and interventional radiologists.旁路手术与血管成形术治疗严重肢体缺血：影响英国外科医生和介入放射科医生治疗偏好的因素。
J Vasc Surg. 2004 May;39(5):1026-32. doi: 10.1016/j.jvs.2004.01.031.
Zotero 插件